Related Experiment Videos
Clinical aspects of thyrocalcitonin
Clinical Orthopaedics and Related Research
|September 1, 1975
Summary
Thyrocalcitonin (TCT) aids in diagnosing thyroid cancer by detecting elevated levels. It also shows therapeutic promise for Paget
Area of Science:
- Endocrinology
- Oncology
- Nephrology
Background:
- Thyrocalcitonin (TCT) is a hormone with diagnostic and therapeutic applications.
- Elevated TCT levels are indicative of medullary thyroid carcinoma and can be found in asymptomatic relatives.
- TCT levels may also be elevated in certain extrathyroidal neoplasms, renal failure, pregnancy, and the neonatal period.
Purpose of the Study:
- To explore the diagnostic utility of TCT in medullary thyroid carcinoma.
- To investigate the therapeutic potential of TCT in various bone disorders and hypercalcemia.
- To clarify the physiological role of TCT in humans.
Main Methods:
- Measurement of plasma TCT levels in patients and their relatives.
- Provocative stimuli tests to assess TCT release.
- Clinical trials evaluating TCT as a therapeutic agent.
Main Results:
- Plasma TCT levels are valuable for diagnosing and managing medullary thyroid carcinoma.
- TCT has demonstrated dramatic therapeutic effects in Paget's disease of bone.
- Encouraging but inconclusive therapeutic responses observed in hypercalcemic subjects.
Conclusions:
- TCT is a significant diagnostic marker for medullary thyroid carcinoma.
- TCT offers a unique therapeutic option for Paget's disease.
- Further research is needed to establish the therapeutic role of TCT in hypercalcemia and osteopenia.